-
Email -
Telephone
Kliovance
Tablets
- Easy to take tablets
- Relieves monopausal symptoms
- Combined HRT
Price Checker
£29.99
Kliovance Medical Information
Kliovance is a continuous combined Hormone Replacement Therapy (HRT). It contains two types of female hormones, an oestrogen and a progestagen.
Kliovance is used in postmenopausal women with at least 1 year since their last natural period.
Kliovance is used for:
Relief of symptoms occurring after menopause During the menopause, the amount of oestrogen produced by a woman’s body drops. This can cause symptoms such as hot face, neck and chest (‘hot flushes’). Kliovance alleviates these symptoms after menopause. You will only be prescribed Kliovance if your symptoms seriously hinder your daily life. P
revention of osteoporosis After the menopause some women may develop fragile bones (osteoporosis). You should discuss all available options with your doctor. If you are at an increased risk of fractures due to osteoporosis and other medicines are not suitable for you, you can use Kliovance to prevent osteoporosis after menopause. Kliovance is prescribed for women who have not had their womb removed, and whose periods stopped more than a year ago. There is only limited experience of treating women older than 65 years with Kliovance.
Take one tablet once a day, at about the same time each day. Once you have finished all the 28 tablets in the pack, start a new pack continuing the treatment without interruption.
For further information on the use of the calendar pack, see ‘User Instructions’ at the end of the package leaflet.
You may start treatment with Kliovance on any convenient day. However, if you are switching from an HRT product when you have monthly bleeding, start your treatment straight after the bleeding has ended.
▪ Allergy to (hypersensitive) to conjugated oestrogens or any of the other ingredients of this medicine
▪ History of breast cancer
▪ Cancer which is sensitive to oestrogens such as cancer of the lining of the womb (endometrium) or if you are suspected of having it
▪ Any unexplained vaginal bleeding
▪ Excessive thickening of the womb lining (endometrial hyperplasia) that is not being treated
▪ History of a blood clot in a vein (thrombosis), such as in the legs (deep venous thrombosis) or the lungs (pulmonary embolism)
▪ A blood clotting disorder (such as protein C, protein S, or antithrombin deficiency)
▪ History of a disease caused by blood clots in the arteries, such as a heart attack, stroke or angina
▪ History of liver disease
▪ History of a rare blood problem called “porphyria” which is passed down in families (inherited)
▪ Pregnancy
• Breast-feeding
Very common side effects (may affect more than 1 in 10 people)
• Breast pain or breast tenderness
• Vaginal bleeding.
Common side effects (may affect up to 1 in 10 people)
• Headache
• Weight gain caused by fluid retention
• Vaginal inflammation
• Migraine, new or worse than before
• Vaginal infection with a fungus
• Depression, new or worse than before
• Nausea
• Abdominal pain, swelling or discomfort
• Enlargement or swelling of the breasts (breast oedema)
• Back pain
• Leg cramps
• Uterine fibroid (benign tumour), aggravation, occurrence or recurrence
• Swelling of arms and legs (peripheral oedema)
• Weight increase.
See other combined HRT products
